Saturday, October 3, 2026

Platinum Futures Went Up By Over 9% In The Last 10 Sessions

ViaNews Editorial Team

September 16, 2024

Platinum Futures Went Up By Over 9% In The Last 10 Sessions

(VIANEWS) - Platinum (PL) has been up by 9.37% for the last 10 sessions. At 08:52 EST on Monday, 16 September, Platinum (PL) is $994.70.

Volume

Today's last reported volume for Platinum is 11393, 99.99% below its average volume of 7068720787.06.

Volatility

Platinum's last week, last month's, and last quarter's current intraday variation average was 1.69%, 0.91%, and 1.29%, respectively.

Platinum's highest amplitude of average volatility was 2.12% (last week), 1.19% (last month), and 1.29% (last quarter), respectively.

Commodity Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Platinum's commodity is considered to be oversold (<=20).

News about

  • According to FXStreet on Monday, 16 September, "This comes on top of a downward revision of demand growth forecasts by the Organization of Petroleum Exporting Countries (OPEC) and the International Energy Agency (IEA) and prompts fresh selling around Crude Oil prices. "
  • According to FXStreet on Monday, 16 September, "The downside, however, seems cushioned in the wake of weaker Crude Oil prices, which tends to undermine the commodity-linked Loonie.", "This, in turn, fails to assist Crude Oil prices to capitalize on last week's recovery from the lowest level since May 2023. "
  • Crude oil dips after soft Chinese data adds more downside pressure. According to FXStreet on Monday, 16 September, "Traders would stem a bigger rate cut as supportive of growth and demand, supporting Crude Oil prices.", "A bigger-than-expected rate cut could see Crude Oil rally in the assumption that demand would pick up and lower rates would unfreeze shelved projects and investments that demand Oil to be developed."

More news about Platinum (PL).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com